T-SPOT.TB assay usage in adults and children

Expert Review of Molecular Diagnostics

Volumn 11, Issue 6, 2011, Pages 643-660

  Soysal, Ahmet ^a,b   Bakir, Mustafa ^a,b  

^a MARMARA UNIVERSITY   (Turkey)

^b Mimar Sinan Caddesi ÜÜst Kaynarca ^*  (Turkey)

Author keywords

IFN release assays; T SPOT.TB; TB infection

Indexed keywords

BCG VACCINE; CULTURE FILTRATE PROTEIN 10; EARLY SECRETORY ANTIGENIC TARGET 6; GAMMA INTERFERON; TUBERCULIN;

BCG VACCINATION; CD4+ T LYMPHOCYTE; CEREBROSPINAL FLUID; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FOLLOW UP; GENE AMPLIFICATION; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IMMUNOCOMPROMISED PATIENT; INCIDENCE; INTERFERON GAMMA RELEASE ASSAY; LUNG LAVAGE; LUNG TUBERCULOSIS; MORTALITY; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PLEURA FLUID; PRACTICE GUIDELINE; REVIEW; SPUTUM; T LYMPHOCYTE; TUBERCULIN TEST; TUBERCULOSIS; TUBERCULOUS MENINGITIS;

ADULT; CHILD; HUMANS; INTERFERON-GAMMA; LYMPHOCYTE COUNT; MOLECULAR DIAGNOSTIC TECHNIQUES; SENSITIVITY AND SPECIFICITY; T-LYMPHOCYTES; TUBERCULOSIS, PLEURAL; TUBERCULOSIS, PULMONARY;

EID: 79960272743     PISSN: 14737159     EISSN: 17448352     Source Type: Journal    
DOI: 10.1586/erm.11.46     Document Type: Review

References (106)

1. Linnroth K, Raviglione M. Global epidemiology of tuberculosis: prospects for control. Semin. Respir. Crit. Care Med. 29(5), 481-491 (2008)
2. WHO. Forty-fourth World Health Assembly. WHA44/1991/REC/1. WHO, Geneva, Switzerland (1991)
3. Comstock GW, Livesay VT, Woolpert SF. The prognosis of a positive tuberculin reaction in childhood and adolescence. Am. J. Epidemiol. 99, 131-138 (1974)
4. Lalvani A, Pareek M. A 100 year update on diagnosis of tuberculosis infection. Br. Med. Bull. 9, 69-84 (2010)
5. Mahairas GG, Sabo PJ, Hickey MJ et al. Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis. J. Bacteriol. 178, 1274-1282 (1996) (Pubitemid 26073382)
6. Andersen P, Andersen AB, Sorensen AL, Nagai S. Recall of long-lived immunity to Mycobacterium tuberculosis infection in mice. J. Immunol. 154, 3359-3372 (1995)
7. Brandt L, Oettinger T, Holm A, Andersen AB, Andersen P. Key epitopes on the ESAT-6 antigen recognized in mice during the recall of protective immunity to Mycobacterium tuberculosis. J. Immunol. 157, 3527-3533 (1996) (Pubitemid 126449166)
8. Pollock JM, Andersen P. Predominant recognition of the ESAT-6 protein in the first phase of interferon with Mycobacterium bovis in cattle. Infect. Immun. 65, 2587-2592 (1997) (Pubitemid 27264082)
9. Ulrichs T, Munk ME, Mollenkopf H et al. Differential T cell responses to Mycobacterium tuberculosis ESAT6 in tuberculosis patients and healthy donors. Eur. J. Immunol. 28, 3949-3958 (1998) (Pubitemid 28558625)
10. Mustafa AS, Amoudy HA, Wiker HG et al. Comparison of antigen-specific T-cell responses of tuberculosis patients using complex or single antigens of Mycobacterium tuberculosis. Scand. J. Immunol. 48, 535-543 (1998) (Pubitemid 28505680)
11. Ravn P, Demissie A, Eguale T et al. Human T cell responses to the ESAT-6 antigen from Mycobacterium tuberculosis. J. Infect. Dis. 179, 637-645 (1999) (Pubitemid 30016147)
12. Mori T, Sakatani M, Yamagishi F et al. Specific detection of tuberculosis infection: an interferon-I-based assay using new antigens. Am. J. Respir. Crit. Care Med. 170, 59-64 (2004) (Pubitemid 38997752)
13. Wood PR, Corner LA, Plackett P. Development of a simple, rapid in vitro cellular assay for bovine tuberculosis based on the production of g interferon. Res. Vet. Sci. 49(1), 46-49 (1990)
14. Wood PR, Corner LA, Rothel JS et al. Field comparison of the interferon-g assay and the intradermal tuberculin test for the diagnosis of bovine tuberculosis. Aust. Vet. J. 68(9), 286-290 (1991)
15. Mazurek GH, Jereb J, Vernon A, LoBue P, Goldberg S, Castro K; IGRA Expert Committee; Centers for Disease Control and Prevention (CDC). Updated guidelines for using interferon g release assays to detect Mycobacterium tuberculosis infection - United States, 2010. MMWR Recomm. Rep. 59(RR-5), 1-25 (2010)
16. Lalvani A, Brookes R, Hambleton S, Britton WJ, Hill AV, McMichael AJ. Rapid effector function in CD8+ memory T cells. J. Exp. Med. 186(6), 859-865 (1997) (Pubitemid 27407347)
17. Lalvani A. Diagnosing tuberculosis infection in the 21st Century: new tools to tackle an old enemy. Chest 131(6), 1898-1906 (2007)
18. Lalvani A, Pathan AA, McShane H et al. Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Am. J. Respir. Crit. Care Med. 163(4), 824-828 (2001) (Pubitemid 32275850)
19. Sester M, Sotgiu G, Lange C et al. Interferon-g release assays for the diagnosis of active tuberculosis: a systemic review and meta analysis. Eur. Respir. J. 37(1), 100-111 (2011)
20. Diel R, Loddenkemper R, Nienhaus A. Evidence-based comparison of commercial interferon-g release assays for detecting active TB: a meta analysis. Chest 137(4), 952-968 (2010)
21. Hopewell PC. Tuberculosis and other mycobacterial diseases. In:Murray and Nadel's Textbook of Respiratory Medicine (4th Edition). Mason RJ, Broaddus VC, Murray JF, Nadel JA (Eds). Saunders, PA, USA, 984-1026 (2005)
22. Shingadia D, Novelli V. Diagnosis and treatment of tuberculosis in children. Lancet Infect. Dis. 3, 624-632 (2003) (Pubitemid 37210226)
23. Liao CH, Chou CH, Lai CC et al. Diagnostic performance of an enzyme-linked immunospot assay for interferon-g in extrapulmonary tuberculosis varies between different sites of disease. J. Infect. 59(6), 402-428 (2009)
24. Kim SH, Cho OH, Park SJ et al. Diagnosis of abdominal tuberculosis by T-cell-based assays on peripheral blood and peritoneal fluid mononuclear cells. J. Infect. 59(6), 409-415 (2009)
25. Losi M, Bossink A, Codecasa L et al. Use of a T-cell interferon-g release assay for the diagnosis of tuberculous pleurisy. Eur. Respir. J. 30(6), 1173-1179 (2007) (Pubitemid 351194766)
26. Lee LN, Chou CH, Wang JY et al. Enzyme-linked immunospot assay for interferon-g in the diagnosis of tuberculous pleurisy. Clin. Microbiol. Infect. 15(2), 173-179 (2009)
27. Dheda K, van Zyl-Smit RN, Sechi LA et al. Utility of quantitative T-cell responses versus unstimulated interferon-g for the diagnosis of pleural tuberculosis. Eur. Respir. J. 34(5), 1118-1126 (2009)
28. Hanna BA, Ebrahimzadeh A, Elliott LB et al. Multicenter evaluation of the BACTEC MGIT 960 system for recovery of mycobacteria. J. Clin. Microbiol. 37, 748-752 (1999) (Pubitemid 29091296)
29. American Thoracic Society, Centers for Disease Control and Prevention. Diagnostic standards and classification of tuberculosis in adults and children. Am. J. Respir. Crit. Care Med. 161, 1376-1395 (2000)
30. Pfyffer GE. [Ranking of the polymerase chain reaction (PCR) and on other amplification methods in the diagnosis of tuberculosis]. Pneumologie 58, 160-164 (2004) (Pubitemid 38392203)
31. Jafari C, Ernst M, Kalsdorf B et al. Rapid diagnosis of smear-negative tuberculosis by bronchoalveolar lavage enzyme-linked immunospot. Am. J. Respir. Crit. Care Med. 174(9), 1048-1054 (2006) (Pubitemid 44684455)
32. Jafari C, Thijsen S, Sotgiu G et al. Bronchoalveolar lavage enzyme-linked immunospot for a rapid diagnosis of tuberculosis: a Tuberculosis Network European Trials group study. Am. J. Respir. Crit. Care Med. 180(7), 666-673 (2009)
33. Thwaites GE, Nguyen DB, Nguyen HD et al. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N. Engl. J. Med. 351, 1741-1751 (2004)
34. Kilpatrick ME, Girgis NI, Yassin MW, Abu El Ella AA. Tuberculosis meningitis - clinical and laboratory review of 100 patients. J. Hyg. (Lond.) 96, 231-238 (1986) (Pubitemid 16117618)
35. Thwaites GE, Chau TT, Farrar JJ. Improving the bacteriologica diagnosis of tuberculous meningitis. J. Clin. Microbiol. 42, 378-337 (2002.)
36. Thomas MM, Hinks TS, Raghuraman S et al. Rapid diagnosis of Mycobacterium tuberculosis meningitis by enumeration of cerebrospinal fluid antigen-specific T-cells. Int. J. Tuberc. Lung Dis. 12(6), 651-657 (2008) (Pubitemid 351846763)
37. Kim SH, Chu K, Choi SJ et al. Diagnosis of central nervous system tuberculosis by T-cell-based assays on peripheral blood and cerebrospinal fluid mononuclear cells. Clin. Vaccine Immunol. 15(9), 1356-1362 (2008)
38. Kim SH, Cho OH, Park SJ et al. Rapid diagnosis of tuberculous meningitis by T cell-based assays on peripheral blood and cerebrospinal fluid mononuclear cells. Clin. Infect. Dis. 50(10), 1349-1358 (2010)
39. Patel VB, Singh R, Connolly C et al. Cerebrospinal T-cell responses aid in the diagnosis of tuberculous meningitis in a human immunodeficiency virus- and tuberculosis-endemic population. Am. J. Respir. Crit. Care Med. 182(4), 569-577 (2010)
40. Dheda K, Lalvani A, Miller RF et al. Performance of a T-cell-based diagnostic test for tuberculosis infection in HIV-infected individuals is independent of CD4 cell count. AIDS 19(17), 2038-2041 (2005) (Pubitemid 41669032)
41. Cattamanchi A, Smith R, Steingart KR et al. Interferon-g release assays for the diagnosis of latent tuberculosis infection in HIV-infected individuals: a systematic review and meta-analysis. J. Acquir. Immune Defic. Syndr. 56(3), 230-238 (2011)
42. Richeldi L, Losi M, D'Amico R et al. Performance of tests for latent tuberculosis in different groups of immunocompromised patients. Chest 136(1), 198-204 (2009)
43. Piana F, Codecasa LR, Cavallerio P et al. Use of a T-cell-based test for detection of tuberculosis infection among immunocompromised patients. Eur. Respir. J. 28(1), 31-34 (2006) (Pubitemid 44914257)
44. Bocchino M, Matarese A, Bellofiore B et al. Performance of two commercial blood IFN-g release assays for the detection of Mycobacterium tuberculosis infection in patient candidates for anti-TNF-a treatment. Eur. J. Clin. Microbiol. Infect. Dis. 27(10), 907-913 (2008)
45. Vassilopoulos D, Stamoulis N, Hadziyannis E, Archimandritis AJ. Usefulness of enzyme-linked immunospot assay (ELISpot) compared with tuberculin skin testing for latent tuberculosis screening in rheumatic patients scheduled for anti-tumor necrosis factor treatment. J. Rheumatol. 35(7), 1271-1276 (2008) (Pubitemid 352000770)
46. Laffitte E, Janssens JP, Roux-Lombard P et al. Tuberculosis screening in patients with psoriasis before antitumour necrosis factor therapy: comparison of an interferon-g release assay vs. tuberculin skin test. Br. J. Dermatol. 161(4), 797-800 (2009)
47. Behar SM, Shin DS, Maier A, Coblyn J, Helfgott S, Weinblatt ME. Use of the T-SPOT.TB assay to detect latent tuberculosis infection among rheumatic disease patients on immunosuppressive therapy. J. Rheumatol. 36(3), 546-551 (2009)
48. Solovic I, Sester M, Gomez-Reino JJ et al. The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement. Eur. Respir. J. 36(5), 1185-1206 (2010)
49. Cengiz K. Increased incidence of tuberculosis in patients undergoing hemodialysis. Nephron 73, 421-424 (1996) (Pubitemid 26229696)
50. Smirnoff M, Patt C, Seckler B, Adler JJ. Tuberculin and anergy skin testing of patients receiving long-term hemodialysis. Chest 11, 25-27 (1998) (Pubitemid 28044919)
51. Passalent L, Khan K, Richardson R, Wang J, Dedier H, Gardam M. Detecting latent tuberculosis infection in hemodialysis patients: a head-to-head comparison of the T-SPOT.TB test, tuberculin skin test, and an expert physician panel. Clin. J. Am. Soc. Nephrol. 2(1), 68-73 (2007)
52. Lee SS, Chou KJ, Su IJ et al. High prevalence of latent tuberculosis infection in patients in end-stage renal disease on hemodialysis: comparison of QuantiFERON-TB GOLD, ELISPOT, and tuberculin skin test. Infection 37(2), 96-102 (2009)
53. Triverio PA, Bridevaux PO, Roux- Lombard P et al. Interferon-g release assays versus tuberculin skin testing for detection of latent tuberculosis in chronic haemodialysis patients. Nephrol. Dial. Transplant. 24(6), 1952-1956 (2009)
54. Chung WK, Zheng ZL, Sung JY et al. Validity of interferon-I-release assays for the diagnosis of latent tuberculosis in haemodialysis patients. Clin. Microbiol. Infect. 16(7), 960-965 (2010)
55. American Academy of Pediatrics. Tuberculosis. In:Red Book: 2009 Report of the Committee on Infectious Diseases (28th Edition). Pickering LK (Ed.). American Academy of Pediatrics, IL, USA, 680 (2009)
56. van den Bos F, Terken M, Ypma L et al. Tuberculous meningitis and miliary tuberculosis in young children. Trop. Med. Int. Health 9(2), 309-313 (2004) (Pubitemid 38250821)
57. Liebeschuetz S, Bamber S, Ewer K, Deeks J, Pathan AA, Lalvani A. Diagnosis of tuberculosis in South African children with a T-cell-based assay: a prospective cohort study. Lancet 364(9452), 2196-2203 (2004) (Pubitemid 40018449)
58. Kampmann B, Whittaker E, Williams A et al. Interferon-g release assays do not identify more children with active tuberculosis than the tuberculin skin test. Eur. Respir. J. 33(6), 1374-1382 (2009)
59. Nicol MP, Pienaar D, Wood K et al. Enzyme-linked immunospot assay responses to early secretory antigenic target 6, culture filtrate protein 10, and purified protein derivative among children with tuberculosis: implications for diagnosis and monitoring of therapy. Clin. Infect. Dis. 40(9), 1301-1308 (2005) (Pubitemid 40570240)
60. Davies MA, Connell T, Johannisen C et al. Detection of tuberculosis in HIV-infected children using an enzyme-linked immunospot assay. AIDS 23(8), 961-969 (2009)
61. Cruz AT, Geltemeyer AM, Starke JR, Flores JA, Graviss EA, Smith KC. Comparing the tuberculin skin test and T-SPOT.TB blood test in children. Pediatrics 127(1), E31-E38 (2011)
62. Nicol MP, Davies MA, Wood K et al. Comparison of T-SPOT.TB assay and tuberculin skin test for the evaluation of young children at high risk for tuberculosis in a community setting. Pediatrics 123(1), 38-43 (2009)
63. Bamford AR, Crook AM, Clark JE et al. Comparison of interferon-g release assays and tuberculin skin test in predicting active tuberculosis (TB) in children in the UK: a paediatric TB network study. Arch. Dis. Child. 95(3), 180-186 (2010)
64. Detjen AK, Keil T, Roll S et al. Interferon-g release assays improve the diagnosis of tuberculosis and nontuberculous mycobacterial disease in children in a country with a low incidence of tuberculosis. Clin. Infect. Dis. 45(3), 322-328 (2007) (Pubitemid 47101028)
65. Ewer K, Deeks J, Alvarez L et al. Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet 361(9364), 1168-1173 (2003) (Pubitemid 36398385)
66. Richeldi L, Ewer K, Losi M et al. T cell-based tracking of multidrug resistant tuberculosis infection after brief exposure. Am. J. Respir. Crit. Care Med. 170(3), 288-295 (2004) (Pubitemid 38971414)
67. Soysal A, Millington KA, Bakir M et al. Effect of BCG vaccination on risk of Mycobacterium tuberculosis infection in children with household tuberculosis contact: a prospective community-based study. Lancet 366(9495), 1443-1451 (2005) (Pubitemid 41483810)
68. Connell TG, Ritz N, Paxton GA, Buttery JP, Curtis N, Ranganathan SC. A three-way comparison of tuberculin skin testing, QuantiFERON-TB Gold and T-SPOT.TB in children. PLoS One 3(7), E2624 (2008)
69. Domínguez J, Ruiz-Manzano J, De Souza-Galvão M et al. Comparison of two commercially available g interferon blood tests for immunodiagnosis of tuberculosis. Clin. Vaccine Immunol. 15(1), 168-171 (2008) (Pubitemid 351966546)
70. Altet-Gómez N, De Souza-Galvao M, Latorre I et al. Diagnosing TB infection in children: analysis of discordances using in vitro tests and tuberculin skin test. Eur. Respir. J. 37(5), 1166-1174 (2010)
71. Soysal A, Turel O, Toprak D, Bakir M. Comparison of positive tuberculin skin test with an interferon-g-based assay in unexposed children. Jpn J. Infect. Dis. 61(3), 192-195 (2008) (Pubitemid 351888588)
72. Hill PC, Brookes RH, Adetifa IM et al. Comparison of enzyme-linked immunospot assay and tuberculin skin test in healthy children exposed to Mycobacterium tuberculosis. Pediatrics 117(5), 1542-1548 (2006)
73. Adetifa IM, Ota MO, Jeffries DJ et al. Commercial interferon g release assays compared with the tuberculin skin test for diagnosis of latent Mycobacterium tuberculosis infection in childhood contacts in the Gambia. Pediatr. Infect. Dis. J. 29(5), 439-443 (2010)
74. Hansted E, Andriuskeviciene A, Sakalauskas R, Kevalas R, Sitkauskiene B. T-cell-based diagnosis of tuberculosis infection in children in Lithuania: a country of high incidence despite a high coverage with bacille Calmette-Guerin vaccination. BMC Pulm. Med. 9, 41 (2009)
75. Lucas M, Nicol P, McKinnon E et al. A prospective large-scale study of methods for the detection of latent Mycobacterium tuberculosis infection in refugee children. Thorax 65(5), 442-448 (2010)
76. Hesseling AC, Mandalakas AM, Kirchner HL et al. Highly discordant T cell responses in individuals with recent exposure to household tuberculosis. Thorax 64(10), 840-846 (2009)
77. Mandalakas AM, Hesseling AC, Chegou NN et al. High level of discordant IGRA results in HIV-infected adults and children. Int. J. Tuberc. Lung Dis. 12(4), 417-423 (2008) (Pubitemid 351507255)
78. Bruzzese E, Bocchino M, Assante LR et al. g interferon release assays for diagnosis of tuberculosis infection in immune-compromised children in a country in which the prevalence of tuberculosis is low. J. Clin. Microbiol. 47(7), 2355-2357 (2009)
79. Haustein T, Ridout DA, Hartley JC et al. The likelihood of an indeterminate test result from a whole-blood interferon-g release assay for the diagnosis of Mycobacterium tuberculosis infection in children correlates with age and immune status. Pediatr. Infect. Dis. J. 28(8), 669-673 (2009)
80. Stefan DC, Dippenaar A, Detjen AK et al. Interferon-g release assays for the detection of Mycobacterium tuberculosis infection in children with cancer. Int. J. Tuberc. Lung Dis. 14(6), 689-694 (2010)
81. Bakir M, Dosanjh DP, Deeks JJ et al. Use of T cell-based diagnosis of tuberculosis infection to optimise interpretation of tuberculin skin testing for child tuberculosis contacts. Clin. Infect. Dis. 48(3), 302-312 (2009)
82. Bakir M, Dosanjh DP, Deeks JJ et al. Prognostic value of a T-cell-based interferon-g biomarker in children with tuberculosis contact. Ann. Intern. Med. 149(11), 777-787 (2008)
83. Kik SV, Franken WP, Mensen M,et al. Predictive value for progression to tuberculosis by IGRA and TST in immigrant contacts. Eur. Respir. J. 35(6), 1346-1353 (2010)
84. Mack U, Migliori GB, Sester M et al. LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement. Eur. Respir. J. 33(5), 956-973 (2009)
85. van Zyl-Smit RN, Zwerling A, Dheda K, Pai M. Within-subject variability of interferon-g assay results for tuberculosis and boosting effect of tuberculin skin testing: a systematic review. PLoS One 4(12), E8517 (2009)
86. Pathan AA, Wilkinson KA, Klenerman P et al. Direct ex vivo analysis of antigen-specific IFN-g-secreting CD4 T cells in Mycobacterium tuberculosis-infected individuals: associations with clinical disease state and effect of treatment. J. Immunol. 167(9), 5217-5225 (2001) (Pubitemid 33009758)
87. Meier T, Eulenbruch HP, Wrighton- Smith P, Enders G, Regnath T. Sensitivity of a new commercial enzyme-linked immunospot assay (T SPOT-TB) for diagnosis of tuberculosis in clinical practice. Eur. J. Clin. Microbiol. Infect. Dis. 24(8), 529-536 (2005) (Pubitemid 41414002)
88. Goletti D, Vincenti D, Carrara S et al. Selected RD1 peptides for active tuberculosis diagnosis: comparison of a g interferon whole-blood enzyme-linked immunosorbent assay and an enzyme-linked immunospot assay. Clin. Diagn. Lab. Immunol. 12(11), 1311-1316 (2005) (Pubitemid 41626601)
89. Goletti D, Carrara S, Vincenti D et al. Accuracy of an immune diagnostic assay based on RD1 selected epitopes for active tuberculosis in a clinical setting: a pilot study. Clin. Microbiol. Infect. 12(6), 544-550 (2006) (Pubitemid 43740765)
90. Ferrara G, Losi M, D'Amico R et al. Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study. Lancet 367(9519), 1328-1334 (2006)
91. Lee JY, Choi HJ, Park IN et al. Comparison of two commercial interferon-g assays for diagnosing Mycobacterium tuberculosis infection. Eur. Respir. J. 28(1), 24-30 (2006) (Pubitemid 44914256)
92. Kang YA, Lee HW, Hwang SS et al. Usefulness of whole-blood interferon-g assay and interferon-g enzyme-linked immunospot assay in the diagnosis of active pulmonary tuberculosis. Chest 132(3), 959-965 (2007)
93. Wang JY, Chou CH, Lee LN et al. Diagnosis of tuberculosis by an enzyme-linked immunospot assay for interferon-g. Emerg. Infect. Dis. 13(4), 553-558 (2007)
94. Janssens JP, Roux-Lombard P, Perneger T, Metzger M, Vivien R, Rochat T. Quantitative scoring of an interferon-g assay for differentiating active from latent tuberculosis. Eur. Respir. J. 30(4), 722-728 (2007)
95. Soysal A, Torun T, Efe S, Gencer H, Tahaoglu K, Bakir M. Evaluation of cut-off values of interferon-g-based assays in the diagnosis of M. tuberculosis infection. Int. J. Tuberc. Lung Dis. 12(1), 50-56 (2008)
96. Chee CB, Gan SH, Khinmar KW et al. Comparison of sensitivities of two commercial g interferon release assays for pulmonary tuberculosis. J. Clin. Microbiol. 46(6), 1935-1940 (2008) (Pubitemid 351831823)
97. Kobashi Y, Mouri K, Yagi S et al. Clinical evaluation for diagnosing active TB disease and transitional change of two commercial blood tests. Scand. J. Infect. Dis. 40(8), 629-634 (2008)
98. Higuchi K, Kawabe Y, Mitarai S, Yoshiyama T, Harada N, Mori T. Comparison of performance in two diagnostic methods for tuberculosis infection. Med. Microbiol. Immunol. 198(1), 33-37 (2009)
99. Chen X, Yang Q, Zhang M et al. Diagnosis of active tuberculosis in China using an in-house g interferon enzyme-linked immunospot assay. Clin. Vaccine Immunol. 16(6), 879-884 (2009)
100. Tan CK, Lai CC, Chen HW et al. Enzyme-linked immunospot assay for interferon-g to support the diagnosis of tuberculosis in diabetic patients. Scand. J. Infect. Dis. 42(10), 752-756 (2010)
101. Wu X, Li Q, Liang Y et al. Clinical evaluation of a homemade enzyme-linked immunospot assay for the diagnosis of active tuberculosis in China. Mol. Biotechnol. 47(1), 18-25 (2011)
102. Simsek H, Alpar S, Ucar N et al. Comparison of tuberculin skin testing and T-SPOT.TB for diagnosis of latent and active tuberculosis. Jpn J. Infect. Dis. 63(2), 99-102 (2010)
103. Domínguez J, De Souza-Galvao M, Ruiz-Manzano J et al. T-cell responses to the Mycobacterium tuberculosis-specific antigens in active tuberculosis patients at the beginning, during, and after antituberculosis treatment. Diagn. Microbiol. Infect. Dis. 63(1), 43-51 (2009)
104. Goletti D, Carrara S, Butera O et al. Accuracy of immunodiagnostic tests for active tuberculosis using single and combined results: a multicenter TBNET-Study. PLoS One 3(10), E3417 (2008)
105. WHO. Global Tuberculosis control. WHO/HTM/TB/2008.393. World Health Organization, Geneva, Switzerland, 2008 www.who.int/tb/publications/global- report/2008/en/index.html (Accessed 9 January 2009)
106. WHO. TB epidemiology and surveillance workshop www.who.int/tb/ surveillanceworkshop/ trend-analysis/increasing-decreasing- over-under- diagnosis-of- extrapulmonary-tb.htm (Accessed 6 October 2006)